LEADER 02094nam  2200613Ia 450 
001 9910456010603321
005 20200520144314.0
010   $a1-280-19303-4
010   $a9786610193035
010   $a0-309-59862-1
010   $a0-585-15457-0
035   $a(CKB)110986584751592
035   $a(OCoLC)44960724
035   $a(CaPaEBR)ebrary10057046
035   $a(SSID)ssj0000153929
035   $a(PQKBManifestationID)11946761
035   $a(PQKBTitleCode)TC0000153929
035   $a(PQKBWorkID)10406227
035   $a(PQKB)11311572
035   $a(MiAaPQ)EBC3376768
035   $a(Au-PeEL)EBL3376768
035   $a(CaPaEBR)ebr10057046
035   $a(CaONFJC)MIL19303
035   $a(OCoLC)923265953
035   $a(EXLCZ)99110986584751592
100   $a19941206d1995      uy             0
101 0 $aeng
135   $aurcn|||||||||
181   $ctxt
182   $cc
183   $acr
200 00$aFederal regulation of methadone treatment$b[electronic resource] /$fRichard A. Rettig and Adam Yarmolinsky, editors ; Committee on Federal Regulation of Methadone Treatment, Division of Biobehavioral Sciences and Mental Disorders, Institute of Medicine
210   $aWashington, D.C. $cNational Academy Press$d1995
215   $a1 online resource (250 p.) 
300   $aBibliographic Level Mode of Issuance: Monograph
311   $a0-309-05240-8 
320   $aIncludes bibliographical references.
606   $aMethadone maintenance$xGovernment policy$zUnited States
606   $aDrug monitoring$xGovernment policy$zUnited States
606   $aMethadone hydrochloride
608   $aElectronic books.
615  0$aMethadone maintenance$xGovernment policy
615  0$aDrug monitoring$xGovernment policy
615  0$aMethadone hydrochloride.
676   $a353.0084/29
701   $aRettig$b Richard A$0869711
701   $aYarmolinsky$b Adam$0675792
801  0$bMiAaPQ
801  1$bMiAaPQ
801  2$bMiAaPQ
906   $aBOOK
912   $a9910456010603321
996   $aFederal regulation of methadone treatment$92458291
997   $aUNINA